 Roberta Pelanda
Concepts (386)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 51 | 2023 | 769 | 7.670 |
Why?
| | Receptors, Antigen, B-Cell | 28 | 2023 | 107 | 5.020 |
Why?
| | Autoimmunity | 11 | 2022 | 814 | 2.840 |
Why?
| | Central Tolerance | 4 | 2022 | 8 | 2.790 |
Why?
| | Precursor Cells, B-Lymphoid | 6 | 2023 | 34 | 2.250 |
Why?
| | Cell Differentiation | 16 | 2022 | 1699 | 2.250 |
Why?
| | Autoantibodies | 11 | 2022 | 1350 | 1.680 |
Why?
| | Immune Tolerance | 8 | 2021 | 328 | 1.670 |
Why?
| | Lupus Erythematosus, Systemic | 3 | 2022 | 221 | 1.520 |
Why?
| | B-Lymphocyte Subsets | 6 | 2018 | 68 | 1.440 |
Why?
| | T-Lymphocytes | 11 | 2022 | 1745 | 1.330 |
Why?
| | Autoantigens | 7 | 2021 | 396 | 1.160 |
Why?
| | Mice | 62 | 2023 | 14916 | 1.070 |
Why?
| | Signal Transduction | 18 | 2023 | 4521 | 0.980 |
Why?
| | Animals | 71 | 2023 | 31761 | 0.920 |
Why?
| | Mice, Transgenic | 15 | 2021 | 1951 | 0.790 |
Why?
| | Mice, Inbred BALB C | 15 | 2021 | 1151 | 0.780 |
Why?
| | Immunoglobulin Light Chains | 7 | 2014 | 35 | 0.770 |
Why?
| | Mice, Knockout | 19 | 2022 | 2582 | 0.770 |
Why?
| | Receptors, CXCR4 | 1 | 2021 | 78 | 0.740 |
Why?
| | Antibody Formation | 5 | 2018 | 267 | 0.710 |
Why?
| | Models, Animal | 4 | 2019 | 345 | 0.710 |
Why?
| | Spleen | 8 | 2019 | 484 | 0.700 |
Why?
| | CD8-Positive T-Lymphocytes | 6 | 2023 | 689 | 0.670 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2019 | 7 | 0.660 |
Why?
| | Immune System | 3 | 2021 | 173 | 0.660 |
Why?
| | Bone Marrow Cells | 5 | 2022 | 267 | 0.630 |
Why?
| | B-Cell Activation Factor Receptor | 5 | 2018 | 13 | 0.590 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 3 | 2018 | 157 | 0.580 |
Why?
| | Mice, Inbred MRL lpr | 4 | 2022 | 37 | 0.560 |
Why?
| | Antigens, CD | 7 | 2015 | 443 | 0.560 |
Why?
| | Lysophospholipids | 4 | 2023 | 65 | 0.560 |
Why?
| | MAP Kinase Signaling System | 1 | 2018 | 276 | 0.540 |
Why?
| | Flow Cytometry | 10 | 2022 | 1086 | 0.530 |
Why?
| | Cell Proliferation | 5 | 2020 | 2196 | 0.520 |
Why?
| | Lymphocyte Activation | 8 | 2022 | 1044 | 0.520 |
Why?
| | Bone Marrow | 5 | 2023 | 244 | 0.500 |
Why?
| | Receptors, Lysophosphatidic Acid | 6 | 2023 | 29 | 0.470 |
Why?
| | Immunoglobulin kappa-Chains | 6 | 2015 | 18 | 0.460 |
Why?
| | Gene Rearrangement, B-Lymphocyte | 4 | 2007 | 7 | 0.440 |
Why?
| | ras Proteins | 1 | 2014 | 138 | 0.440 |
Why?
| | Immunoglobulin M | 7 | 2023 | 250 | 0.430 |
Why?
| | Receptors, Cytokine | 1 | 2013 | 33 | 0.430 |
Why?
| | Tumor Virus Infections | 2 | 2012 | 43 | 0.420 |
Why?
| | Immunoglobulins | 3 | 2012 | 143 | 0.420 |
Why?
| | Plasma Cells | 1 | 2012 | 56 | 0.400 |
Why?
| | Glucocorticoid-Induced TNFR-Related Protein | 1 | 2012 | 5 | 0.400 |
Why?
| | Rhadinovirus | 1 | 2012 | 16 | 0.400 |
Why?
| | Gene Rearrangement, B-Lymphocyte, Heavy Chain | 3 | 2002 | 12 | 0.400 |
Why?
| | Peripheral Tolerance | 3 | 2022 | 14 | 0.390 |
Why?
| | Guanine Nucleotide Exchange Factors | 5 | 2011 | 55 | 0.380 |
Why?
| | Interleukin Receptor Common gamma Subunit | 1 | 2011 | 15 | 0.380 |
Why?
| | Immunologic Memory | 2 | 2013 | 313 | 0.380 |
Why?
| | Transplantation Chimera | 1 | 2011 | 51 | 0.370 |
Why?
| | Mice, Inbred C57BL | 17 | 2021 | 4710 | 0.370 |
Why?
| | Lymph Nodes | 2 | 2013 | 423 | 0.370 |
Why?
| | Immunoglobulin Heavy Chains | 7 | 2013 | 72 | 0.370 |
Why?
| | Cytokines | 4 | 2023 | 1843 | 0.370 |
Why?
| | Genetic Variation | 1 | 2015 | 876 | 0.360 |
Why?
| | Herpesviridae Infections | 1 | 2012 | 138 | 0.360 |
Why?
| | Genes, Immunoglobulin | 5 | 2000 | 26 | 0.350 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2023 | 330 | 0.310 |
Why?
| | Immunity, Humoral | 3 | 2014 | 112 | 0.310 |
Why?
| | Hematopoietic Stem Cell Transplantation | 3 | 2021 | 524 | 0.310 |
Why?
| | Disease Models, Animal | 10 | 2022 | 3542 | 0.300 |
Why?
| | DNA-Binding Proteins | 5 | 2011 | 1314 | 0.300 |
Why?
| | Immunoglobulin Allotypes | 1 | 2007 | 6 | 0.290 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2020 | 158 | 0.290 |
Why?
| | Immunoglobulin Variable Region | 6 | 2007 | 72 | 0.280 |
Why?
| | Gene Expression Regulation | 5 | 2018 | 2321 | 0.280 |
Why?
| | Antigens, CD19 | 4 | 2015 | 91 | 0.280 |
Why?
| | Transgenes | 2 | 2018 | 170 | 0.270 |
Why?
| | Immunoglobulin Joining Region | 4 | 2002 | 10 | 0.270 |
Why?
| | Integrases | 3 | 2006 | 116 | 0.260 |
Why?
| | Humans | 33 | 2023 | 114714 | 0.260 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 4 | 2018 | 797 | 0.260 |
Why?
| | RNA Editing | 1 | 2005 | 20 | 0.260 |
Why?
| | Antibodies, Neutralizing | 3 | 2020 | 221 | 0.260 |
Why?
| | Immunoglobulin Isotypes | 2 | 2022 | 32 | 0.250 |
Why?
| | Antigens | 3 | 2013 | 318 | 0.250 |
Why?
| | Hybridomas | 3 | 2012 | 230 | 0.230 |
Why?
| | Neoplasms | 3 | 2022 | 2105 | 0.230 |
Why?
| | Cells, Cultured | 8 | 2019 | 3890 | 0.230 |
Why?
| | Proto-Oncogene Proteins | 4 | 2010 | 610 | 0.230 |
Why?
| | Cell Separation | 4 | 2018 | 292 | 0.220 |
Why?
| | Tumor Microenvironment | 3 | 2022 | 433 | 0.220 |
Why?
| | Biliary Atresia | 2 | 2018 | 183 | 0.220 |
Why?
| | HIV-1 | 2 | 2020 | 768 | 0.220 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2023 | 27 | 0.210 |
Why?
| | CD79 Antigens | 4 | 2018 | 16 | 0.210 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 114 | 0.210 |
Why?
| | Enzyme Activation | 2 | 2018 | 787 | 0.210 |
Why?
| | Carcinogenesis | 3 | 2019 | 180 | 0.200 |
Why?
| | Receptors, Cell Surface | 1 | 2004 | 354 | 0.200 |
Why?
| | Immunological Synapses | 1 | 2022 | 18 | 0.200 |
Why?
| | Models, Immunological | 3 | 2018 | 92 | 0.200 |
Why?
| | Homeostasis | 2 | 2018 | 575 | 0.190 |
Why?
| | Immunoglobulin G | 3 | 2018 | 774 | 0.190 |
Why?
| | Female | 11 | 2022 | 59485 | 0.190 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2023 | 1134 | 0.180 |
Why?
| | Immunotherapy | 2 | 2022 | 475 | 0.180 |
Why?
| | Male | 9 | 2022 | 55558 | 0.180 |
Why?
| | Heterografts | 1 | 2021 | 117 | 0.180 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2023 | 399 | 0.180 |
Why?
| | Cell Membrane | 1 | 2004 | 679 | 0.180 |
Why?
| | Adaptive Immunity | 2 | 2018 | 156 | 0.180 |
Why?
| | Mice, Mutant Strains | 3 | 2012 | 271 | 0.180 |
Why?
| | Quinoxalines | 1 | 2020 | 60 | 0.180 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2023 | 368 | 0.170 |
Why?
| | Extracellular Vesicles | 1 | 2021 | 83 | 0.170 |
Why?
| | Viral Proteins | 1 | 2002 | 281 | 0.170 |
Why?
| | Immunoglobulin lambda-Chains | 2 | 2015 | 6 | 0.170 |
Why?
| | Age Factors | 3 | 2013 | 2889 | 0.170 |
Why?
| | Cell Survival | 4 | 2018 | 1021 | 0.160 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2000 | 174 | 0.160 |
Why?
| | Immunity, Innate | 2 | 2018 | 723 | 0.160 |
Why?
| | beta Catenin | 1 | 2020 | 220 | 0.160 |
Why?
| | Stem Cells | 2 | 2002 | 546 | 0.160 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2019 | 155 | 0.160 |
Why?
| | Xenograft Model Antitumor Assays | 4 | 2022 | 706 | 0.160 |
Why?
| | Lymphopoiesis | 1 | 2018 | 24 | 0.150 |
Why?
| | Piperazines | 1 | 2020 | 311 | 0.150 |
Why?
| | Receptors, Complement 3d | 1 | 2019 | 130 | 0.150 |
Why?
| | Retroviridae | 1 | 2018 | 90 | 0.150 |
Why?
| | Bile Ducts | 1 | 2018 | 68 | 0.150 |
Why?
| | Herpesvirus 4, Human | 1 | 2018 | 125 | 0.150 |
Why?
| | Transduction, Genetic | 1 | 2018 | 113 | 0.150 |
Why?
| | Antibodies | 3 | 2015 | 371 | 0.150 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2018 | 72 | 0.150 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2019 | 198 | 0.140 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2018 | 98 | 0.140 |
Why?
| | Membrane Glycoproteins | 2 | 2015 | 429 | 0.140 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 195 | 0.140 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2019 | 152 | 0.140 |
Why?
| | Genetic Vectors | 1 | 2018 | 291 | 0.140 |
Why?
| | Allergens | 1 | 2020 | 413 | 0.140 |
Why?
| | Interleukins | 1 | 2018 | 236 | 0.140 |
Why?
| | Phenotype | 2 | 2021 | 2811 | 0.140 |
Why?
| | HIV Infections | 3 | 2020 | 2469 | 0.130 |
Why?
| | Alleles | 4 | 2007 | 791 | 0.130 |
Why?
| | B-Cell Activating Factor | 2 | 2018 | 18 | 0.130 |
Why?
| | Genes, bcl-2 | 2 | 2018 | 20 | 0.130 |
Why?
| | Histones | 1 | 2020 | 536 | 0.130 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2019 | 618 | 0.130 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2020 | 1147 | 0.120 |
Why?
| | Receptors, Lysosphingolipid | 3 | 2010 | 12 | 0.120 |
Why?
| | Antibody Affinity | 2 | 2012 | 52 | 0.120 |
Why?
| | Graft Rejection | 2 | 2021 | 516 | 0.120 |
Why?
| | Heart Transplantation | 1 | 2021 | 667 | 0.120 |
Why?
| | Immunophenotyping | 1 | 2015 | 275 | 0.120 |
Why?
| | VDJ Recombinases | 3 | 2004 | 4 | 0.120 |
Why?
| | Macrophages, Peritoneal | 2 | 2011 | 91 | 0.120 |
Why?
| | Fibronectins | 2 | 2011 | 108 | 0.110 |
Why?
| | Animals, Newborn | 2 | 2018 | 777 | 0.110 |
Why?
| | Toll-Like Receptors | 2 | 2020 | 166 | 0.110 |
Why?
| | Adoptive Transfer | 2 | 2013 | 198 | 0.110 |
Why?
| | Rotavirus | 1 | 2013 | 22 | 0.110 |
Why?
| | Gene Targeting | 2 | 2006 | 75 | 0.110 |
Why?
| | Azospirillum brasilense | 1 | 1993 | 1 | 0.110 |
Why?
| | Glutamate Synthase | 1 | 1993 | 2 | 0.110 |
Why?
| | Antibody Diversity | 3 | 2007 | 16 | 0.110 |
Why?
| | Kinetics | 3 | 2012 | 1550 | 0.110 |
Why?
| | Clonal Selection, Antigen-Mediated | 1 | 2012 | 3 | 0.100 |
Why?
| | Lymphocyte Count | 1 | 2013 | 133 | 0.100 |
Why?
| | HIV Antibodies | 1 | 2013 | 49 | 0.100 |
Why?
| | Lymphocyte Depletion | 1 | 2013 | 116 | 0.100 |
Why?
| | Genes, Bacterial | 1 | 1993 | 157 | 0.100 |
Why?
| | Toll-Like Receptor 7 | 1 | 2012 | 35 | 0.100 |
Why?
| | Antineoplastic Agents | 1 | 2023 | 1895 | 0.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2015 | 386 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2019 | 621 | 0.100 |
Why?
| | fas Receptor | 1 | 2012 | 92 | 0.100 |
Why?
| | Rho Guanine Nucleotide Exchange Factors | 5 | 2011 | 19 | 0.100 |
Why?
| | Receptors, Thromboxane | 1 | 2011 | 4 | 0.100 |
Why?
| | Immunoglobulin mu-Chains | 2 | 2004 | 7 | 0.100 |
Why?
| | Transplantation, Homologous | 1 | 2013 | 386 | 0.100 |
Why?
| | Lupus Nephritis | 1 | 2012 | 52 | 0.100 |
Why?
| | Mice, Inbred NOD | 3 | 2022 | 561 | 0.100 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2015 | 398 | 0.100 |
Why?
| | Hematopoietic Stem Cells | 3 | 2011 | 345 | 0.100 |
Why?
| | Dendritic Cells | 2 | 2012 | 436 | 0.090 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2011 | 119 | 0.090 |
Why?
| | Cell Communication | 1 | 2013 | 279 | 0.090 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1361 | 0.090 |
Why?
| | Reperfusion Injury | 1 | 2013 | 254 | 0.090 |
Why?
| | Infant, Newborn | 1 | 2021 | 5034 | 0.090 |
Why?
| | Cholestasis | 1 | 2013 | 224 | 0.090 |
Why?
| | Friend murine leukemia virus | 1 | 2010 | 30 | 0.090 |
Why?
| | Cytidine Deaminase | 1 | 2010 | 58 | 0.090 |
Why?
| | Integrins | 2 | 2007 | 79 | 0.090 |
Why?
| | Integrin alpha5beta1 | 1 | 2010 | 9 | 0.090 |
Why?
| | Self Tolerance | 1 | 2010 | 28 | 0.090 |
Why?
| | Proprotein Convertases | 1 | 2010 | 14 | 0.090 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2010 | 129 | 0.080 |
Why?
| | Kidney Diseases | 1 | 2013 | 350 | 0.080 |
Why?
| | Serine Endopeptidases | 1 | 2010 | 102 | 0.080 |
Why?
| | Immunity | 1 | 2010 | 121 | 0.080 |
Why?
| | Autoimmune Diseases | 1 | 2012 | 391 | 0.080 |
Why?
| | Matrix Metalloproteinases | 1 | 2010 | 89 | 0.080 |
Why?
| | Interleukin-6 | 2 | 2023 | 675 | 0.080 |
Why?
| | Immunity, Active | 1 | 2008 | 9 | 0.080 |
Why?
| | Interferon-alpha | 1 | 2010 | 187 | 0.080 |
Why?
| | Macrophages, Alveolar | 1 | 2011 | 347 | 0.080 |
Why?
| | Gene Rearrangement, B-Lymphocyte, Light Chain | 2 | 1998 | 4 | 0.080 |
Why?
| | Molecular Sequence Data | 4 | 2013 | 2791 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 743 | 0.080 |
Why?
| | Virus Replication | 1 | 2010 | 395 | 0.080 |
Why?
| | Mice, Nude | 2 | 2020 | 635 | 0.080 |
Why?
| | Recombination, Genetic | 4 | 2006 | 176 | 0.070 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2007 | 17 | 0.070 |
Why?
| | YY1 Transcription Factor | 1 | 2007 | 27 | 0.070 |
Why?
| | Melanoma | 1 | 2013 | 629 | 0.070 |
Why?
| | Kidney Transplantation | 1 | 2013 | 541 | 0.070 |
Why?
| | Cell Line | 3 | 2020 | 2639 | 0.070 |
Why?
| | Bronchial Hyperreactivity | 1 | 2007 | 95 | 0.070 |
Why?
| | Cell Line, Tumor | 3 | 2019 | 2725 | 0.070 |
Why?
| | Kidney | 1 | 2013 | 1184 | 0.070 |
Why?
| | I-kappa B Kinase | 1 | 2006 | 50 | 0.070 |
Why?
| | Th2 Cells | 1 | 2007 | 154 | 0.070 |
Why?
| | Rats | 1 | 2014 | 4943 | 0.070 |
Why?
| | Binding Sites, Antibody | 1 | 2005 | 36 | 0.060 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2006 | 139 | 0.060 |
Why?
| | Lymphoma, B-Cell | 1 | 2006 | 86 | 0.060 |
Why?
| | HIV Envelope Protein gp120 | 2 | 2017 | 56 | 0.060 |
Why?
| | Cell Movement | 2 | 2008 | 867 | 0.060 |
Why?
| | DNA Nucleotidyltransferases | 2 | 2002 | 11 | 0.060 |
Why?
| | src-Family Kinases | 1 | 2005 | 88 | 0.060 |
Why?
| | Immunoglobulin Class Switching | 2 | 2010 | 15 | 0.060 |
Why?
| | Cell Division | 2 | 2004 | 759 | 0.060 |
Why?
| | Clonal Deletion | 1 | 2004 | 18 | 0.060 |
Why?
| | Base Sequence | 3 | 2004 | 2118 | 0.060 |
Why?
| | Oligodeoxyribonucleotides | 2 | 2015 | 138 | 0.060 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 1999 | 799 | 0.060 |
Why?
| | Mutagenesis | 1 | 2004 | 170 | 0.050 |
Why?
| | Monitoring, Immunologic | 1 | 2023 | 23 | 0.050 |
Why?
| | Hematopoiesis | 1 | 2004 | 172 | 0.050 |
Why?
| | Immunoglobulin D | 1 | 2022 | 27 | 0.050 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 2 | 2014 | 84 | 0.050 |
Why?
| | Lectins, C-Type | 2 | 2014 | 61 | 0.050 |
Why?
| | Transplantation, Heterologous | 1 | 2022 | 183 | 0.050 |
Why?
| | NF-kappa B | 1 | 2006 | 636 | 0.050 |
Why?
| | Crosses, Genetic | 1 | 2002 | 140 | 0.050 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2022 | 26 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2013 | 353 | 0.050 |
Why?
| | Inflammation | 2 | 2022 | 2481 | 0.050 |
Why?
| | Pneumonia | 1 | 2007 | 566 | 0.050 |
Why?
| | Interferons | 1 | 2022 | 151 | 0.050 |
Why?
| | Leukosialin | 2 | 1999 | 15 | 0.050 |
Why?
| | Phosphorylation | 1 | 2005 | 1571 | 0.050 |
Why?
| | Chimerism | 1 | 2021 | 28 | 0.050 |
Why?
| | Lymphoid Tissue | 1 | 2021 | 62 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 928 | 0.050 |
Why?
| | Cytoskeleton | 1 | 2022 | 177 | 0.050 |
Why?
| | Sialoglycoproteins | 2 | 1999 | 158 | 0.050 |
Why?
| | Lymphocyte Subsets | 1 | 2021 | 79 | 0.050 |
Why?
| | Hemagglutination | 1 | 2020 | 7 | 0.050 |
Why?
| | Mice, SCID | 1 | 2021 | 320 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2006 | 1022 | 0.040 |
Why?
| | COS Cells | 1 | 2020 | 175 | 0.040 |
Why?
| | RNA, Viral | 1 | 2023 | 566 | 0.040 |
Why?
| | Homozygote | 1 | 2000 | 187 | 0.040 |
Why?
| | Heterozygote | 1 | 2000 | 251 | 0.040 |
Why?
| | Perforin | 1 | 2019 | 19 | 0.040 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2019 | 44 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2020 | 854 | 0.040 |
Why?
| | Amino Acid Sequence | 2 | 2013 | 1988 | 0.040 |
Why?
| | Exocytosis | 1 | 2019 | 89 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2022 | 521 | 0.040 |
Why?
| | Viral Tropism | 1 | 2018 | 24 | 0.040 |
Why?
| | Lipopolysaccharides | 2 | 2015 | 812 | 0.040 |
Why?
| | Antibodies, Anti-Idiotypic | 1 | 2018 | 54 | 0.040 |
Why?
| | Antigens, Nuclear | 1 | 1998 | 19 | 0.040 |
Why?
| | Virus Activation | 1 | 2018 | 78 | 0.040 |
Why?
| | Virus Latency | 1 | 2018 | 80 | 0.040 |
Why?
| | Immunization | 1 | 2020 | 401 | 0.040 |
Why?
| | Mutagenesis, Insertional | 1 | 1997 | 61 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2020 | 954 | 0.040 |
Why?
| | Leukocyte Common Antigens | 1 | 1997 | 76 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 295 | 0.040 |
Why?
| | Tamoxifen | 1 | 2018 | 192 | 0.040 |
Why?
| | Lung | 1 | 2010 | 3546 | 0.040 |
Why?
| | Antibody Specificity | 2 | 2013 | 176 | 0.040 |
Why?
| | Cross Reactions | 1 | 2017 | 117 | 0.040 |
Why?
| | HIV | 1 | 2018 | 208 | 0.040 |
Why?
| | DNA Helicases | 1 | 1998 | 134 | 0.030 |
Why?
| | Immunoglobulin Light Chains, Surrogate | 1 | 1996 | 1 | 0.030 |
Why?
| | Green Fluorescent Proteins | 2 | 2011 | 373 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 388 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 343 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1996 | 489 | 0.030 |
Why?
| | Cell Adhesion | 2 | 2007 | 430 | 0.030 |
Why?
| | Syk Kinase | 1 | 2015 | 18 | 0.030 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2015 | 35 | 0.030 |
Why?
| | Genes, Reporter | 2 | 2006 | 257 | 0.030 |
Why?
| | GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2014 | 5 | 0.030 |
Why?
| | B7-2 Antigen | 1 | 2014 | 25 | 0.030 |
Why?
| | CD40 Antigens | 1 | 2015 | 82 | 0.030 |
Why?
| | Macrophages | 1 | 2021 | 1261 | 0.030 |
Why?
| | Interleukin-4 | 1 | 2015 | 208 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1635 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2020 | 1270 | 0.030 |
Why?
| | Neoplastic Processes | 1 | 2013 | 4 | 0.030 |
Why?
| | Immunologic Surveillance | 1 | 2013 | 19 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 1998 | 592 | 0.030 |
Why?
| | Calcium | 1 | 2019 | 1103 | 0.030 |
Why?
| | Chromosomes, Bacterial | 1 | 1993 | 7 | 0.030 |
Why?
| | Restriction Mapping | 1 | 1993 | 77 | 0.030 |
Why?
| | Genes, Immunoglobulin Heavy Chain | 1 | 2013 | 10 | 0.030 |
Why?
| | Antigen-Presenting Cells | 1 | 2013 | 153 | 0.030 |
Why?
| | Operon | 1 | 1993 | 59 | 0.030 |
Why?
| | AIDS Vaccines | 1 | 2013 | 41 | 0.030 |
Why?
| | Macromolecular Substances | 1 | 1993 | 200 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 1993 | 524 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2011 | 84 | 0.020 |
Why?
| | Autocrine Communication | 1 | 2011 | 42 | 0.020 |
Why?
| | Apoptosis | 1 | 2020 | 2369 | 0.020 |
Why?
| | Species Specificity | 1 | 2013 | 545 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2013 | 342 | 0.020 |
Why?
| | Arthritis, Rheumatoid | 1 | 1999 | 1002 | 0.020 |
Why?
| | Ficoll | 1 | 2010 | 5 | 0.020 |
Why?
| | Liver | 1 | 2018 | 1631 | 0.020 |
Why?
| | Toll-Like Receptor 3 | 1 | 2010 | 26 | 0.020 |
Why?
| | Retroviridae Infections | 1 | 2010 | 46 | 0.020 |
Why?
| | Poly I-C | 1 | 2010 | 51 | 0.020 |
Why?
| | Receptors, IgG | 1 | 2010 | 67 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2010 | 292 | 0.020 |
Why?
| | DNA Methylation | 2 | 2007 | 496 | 0.020 |
Why?
| | Escherichia coli | 1 | 1993 | 722 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2010 | 271 | 0.020 |
Why?
| | Leukocytes | 1 | 2010 | 277 | 0.020 |
Why?
| | Epitopes | 1 | 2010 | 435 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2010 | 524 | 0.020 |
Why?
| | Cell Membrane Structures | 1 | 2007 | 5 | 0.020 |
Why?
| | RGS Proteins | 1 | 2007 | 12 | 0.020 |
Why?
| | Ligands | 1 | 2010 | 564 | 0.020 |
Why?
| | Models, Molecular | 1 | 2013 | 1378 | 0.020 |
Why?
| | Vaccines | 1 | 2013 | 375 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2007 | 115 | 0.020 |
Why?
| | Gene Expression | 2 | 2006 | 1420 | 0.020 |
Why?
| | Molecular Weight | 1 | 2007 | 331 | 0.020 |
Why?
| | PAX5 Transcription Factor | 1 | 2007 | 12 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2010 | 589 | 0.020 |
Why?
| | Bronchial Provocation Tests | 1 | 2007 | 53 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2010 | 667 | 0.020 |
Why?
| | Cell Polarity | 1 | 2007 | 131 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2007 | 129 | 0.020 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 206 | 0.020 |
Why?
| | DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2006 | 13 | 0.020 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2006 | 18 | 0.020 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2006 | 26 | 0.020 |
Why?
| | Interleukin-7 | 1 | 2006 | 45 | 0.020 |
Why?
| | Protein Transport | 1 | 2007 | 396 | 0.020 |
Why?
| | Genetic Markers | 1 | 2007 | 321 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2007 | 313 | 0.020 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2006 | 110 | 0.020 |
Why?
| | Hyperplasia | 1 | 2006 | 163 | 0.020 |
Why?
| | Polymerase Chain Reaction | 2 | 1999 | 994 | 0.020 |
Why?
| | Genotype | 1 | 2010 | 1773 | 0.020 |
Why?
| | Protein Kinase C-delta | 1 | 2006 | 70 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2007 | 797 | 0.020 |
Why?
| | Gene Deletion | 1 | 2006 | 356 | 0.020 |
Why?
| | Child, Preschool | 1 | 2018 | 9079 | 0.010 |
Why?
| | Cell Lineage | 1 | 2006 | 310 | 0.010 |
Why?
| | DNA Nucleotidylexotransferase | 1 | 2004 | 11 | 0.010 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2004 | 6 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 2004 | 94 | 0.010 |
Why?
| | Chromatin | 1 | 2007 | 428 | 0.010 |
Why?
| | RNA-Binding Proteins | 1 | 2006 | 344 | 0.010 |
Why?
| | Cell Nucleus | 1 | 2006 | 554 | 0.010 |
Why?
| | Luminescent Proteins | 1 | 2004 | 165 | 0.010 |
Why?
| | Epigenesis, Genetic | 1 | 2007 | 521 | 0.010 |
Why?
| | Extracellular Matrix Proteins | 1 | 2004 | 126 | 0.010 |
Why?
| | DNA Primers | 1 | 2004 | 514 | 0.010 |
Why?
| | Down-Regulation | 1 | 2004 | 596 | 0.010 |
Why?
| | Homeodomain Proteins | 1 | 2004 | 463 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 17808 | 0.010 |
Why?
| | Child | 1 | 2018 | 18350 | 0.010 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 1999 | 16 | 0.010 |
Why?
| | Organ Specificity | 1 | 1999 | 268 | 0.010 |
Why?
| | Ku Autoantigen | 1 | 1998 | 13 | 0.010 |
Why?
| | Gene Rearrangement | 1 | 1999 | 138 | 0.010 |
Why?
| | Antigen Presentation | 1 | 1999 | 189 | 0.010 |
Why?
| | Genes, RAG-1 | 1 | 1997 | 11 | 0.010 |
Why?
| | Germinal Center | 1 | 1997 | 48 | 0.010 |
Why?
| | Enhancer Elements, Genetic | 1 | 1998 | 152 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 1999 | 728 | 0.010 |
Why?
|
|
Pelanda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|